April 20, 2014 3:09 AM ET

Biotechnology

Company Overview of Nabi Biopharmaceuticals

Executive Profile

Geoffrey F. Cox Ph.D.

Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, Biota Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships
69$69,157

Background

Dr. Geoffrey F. Cox, PhD is a Partner of Red Sky Partners LLC. Dr. Cox serves as an Independent Consultant to the Biotechnology and Life Sciences Industry and Principal of Beacon Street Advisors. Dr. Cox served as Chairman, Chief Executive Officer and President of rEVO Biologics (formerly, GTC Biotherapeutics Inc.) from July 2001 to June 15, 2010. Dr. Cox served as the Chairman of Aronex Pharmaceuticals Inc. from 1997 to June 2001 and its Chief Executive Officer since ...

Corporate Headquarters

12276 Wilkins Avenue
Rockville, Maryland 20852

United States

Phone: 301-770-3099
Fax: 301-770-3097

Board Members Memberships

Chairman of the Board
Director
Non-Executive Director
Independent Director
1994-N/A
Former Chairman and Chief Executive Officer
2000-N/A
Non-Executive Chairman
2000-Present
Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2001-2010
Former Chairman, Chief Executive Officer and President
2012-Present
Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
2014-Present
Director

Education

BS
University of Birmingham
PhD
University of East Anglia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$32,523
Total Calculated Compensation$69,157
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
$5.1M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nabi Biopharmaceuticals, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.